Example: Heart Attack

Search clinical trials for: Cycloserine

Total 127 results

    • NCT02735694
      Terminated
      Cycloserine in the Treatment of Sleep Apnea
      Conditions: Sleep Apnea Syndromes
    • NCT01362309
      Completed
      D-Cycloserine to Enhance Extinction to Alcohol Cues
      Conditions: Alcohol Use Disorders.
    • NCT03937596
      Active, not recruiting
      Adjunctive D-Cycloserine in Major Depressive Disorder
      Conditions: Major Depressive Disorder
    • NCT01062932
      Completed
      Investigation of Cycloserine as a Smoking Cessation Treatment
      Conditions: Nicotine Addiction
    • NCT00742079
      Completed
      Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
      Conditions: Schizophrenia
    • NCT00964041
      Withdrawn
      Once Weekly D-cycloserine for Schizophrenia
      Conditions: Schizophrenia
    • NCT02772211
      Unknown status
      D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
      Conditions: Treatment Resistant Depression
    • NCT01733030
      Completed
      The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.
      Conditions: Post Traumatic Stress Syndrome
    • NCT01086475
      Completed
      D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
      Conditions: Autistic Disorder; Asperger's Disorder; Pervasive Developmental Disorder NOS
    • NCT01928823
      Completed
      Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia
      Conditions: Agoraphobia
    • NCT03535688
      Recruiting
      D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain
      Conditions: Low Back Pain; Pain
    • NCT02304432
      Completed
      Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
      Conditions: Schizophrenia; Bipolar Disorder
    • NCT00455702
      Completed
      Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
      Conditions: Schizophrenia
    • NCT01649895
      Completed
      D-Cycloserine as an Adjunct to Internet-CBT for OCD
      Conditions: Obsessive-compulsive Disorder
    • NCT01343862
      Unknown status
      The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients
      Conditions: Traumatic Brain Injury
    • NCT00842309
      Completed
      D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
      Conditions: Body Dysmorphic Disorder
    • NCT01981759
      Completed
      D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
      Conditions: Schizophrenia; Schizoaffective Disorder; Delusional Disorder
    • NCT01361633
      Completed
      The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
      Conditions: Treatment; Placebo
    • NCT02933684
      Withdrawn
      D-Cycloserine and Virtual Reality Exposure Therapy
      Conditions: Social Anxiety Disorder
    • NCT00198120
      Completed
      Safety and Effectiveness of D-Cycloserine in Children With Autism
      Conditions: Autistic Disorder
    • NCT00000371
      Completed
      Trial of D-Cycloserine in Schizophrenia
      Conditions: Schizophrenia
    • NCT01985750
      Unknown status
      Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception
      Conditions: Chronic Obstructive Pulmonary Disease
    • NCT02582515
      Completed
      Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
      Conditions: Tourette Disorder; Chronic Tic Disorder
    • NCT00963924
      Completed
      D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
      Conditions: Schizophrenia
    • NCT02983734
      Unknown status
      D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)
      Conditions: Gulf War Illness
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations